Picture of Maia Biotechnology logo

MAIA — Maia Biotechnology News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Brief: Joseph Mcguire And Mihail Obrocea Terminated From Their Positions at Maia Biotechnology

Nov 15 (Reuters) - Maia Biotechnology Inc  MAIA.A :
    * MAIA BIOTECHNOLOGY - ON NOV 10, JOSEPH MCGUIRE AND MIHAIL
OBROCEA WERE TERMINATED FROM THEIR POSITIONS AS CFO AND CHIEF
MEDICAL OFFICER  RESPECTIVELY
    * MAIA BIOTECHNOLOGY- ON NOV 10, CO APPOINTED JEFFREY
HIMMELREICH
AS ITS HEAD OF FINANCE AND PRINCIPAL FINANCIAL AND ACCOUNTING
OFFICER
    * MAIA BIOTECHNOLOGY INC: SUSPENDED SALES OF ITS COMMON
STOCK
PURSUANT TO THAT CERTAIN SALES AGREEMENT DATED SEPT 1, BETWEEN
CO & THINKEQUITY
    * MAIA BIOTECHNOLOGY INC: CO PROVIDED NOTICE TO THINKEQUITY
THAT
IT IS TERMINATING SALES AGREEMENT WHICH WILL BE EFFECTIVE 10
DAYS AFTER NOV 15, 2023
    * MAIA BIOTECHNOLOGY: ON NOV 14, NYSE AMERICAN SAID BELIEVES
CO IS
NOT IN COMPLIANCE WITH CONTINUED LISTING STANDARDS RELATING TO
STOCKHOLDERS’ EQUITY


Further company coverage:  MAIA.A 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Maia Biotechnology

See all news